Relenza verdict forces 'fasttrack' re-think

The National Institute for Clinical Excellence is to review its fast-track appraisal procedure following outgoing health secretary Frank Dobson's decision to reject Relenza for NHS prescription this winter.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here